CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Assets
Cash and due from banks	$ 376,216	$ 411,412
Interest bearing deposits with banks	994,224	1,478,713
Investment securities:
Equity securities	78,296	71,513
Available for sale debt securities	4,117,121	3,369,724
Held to maturity debt securities (net of allowance for credit losses of $637 at September 30, 2025 and $647 at December 31, 2024)	3,540,819	3,531,573
Total investment securities	7,736,236	6,972,810
Loans held for sale (includes fair value of $5,405 at September 30, 2025 and $16,931 at December 31, 2024 for loans originated for sale)	18,092	25,681
Loans	49,272,823	48,799,711
Less: Allowance for loan losses	(585,000)	(558,850)
Net loans	48,687,823	48,240,861
Premises and equipment, net	331,134	350,796
Lease right of use assets	318,373	328,475
Bank owned life insurance	739,684	731,574
Accrued interest receivable	242,861	239,941
Goodwill	1,868,936	1,868,936
Other intangible assets, net	107,658	128,661
Other assets	1,597,377	1,713,831
Total Assets	63,018,614	62,491,691
Deposits:
Non-interest bearing	11,659,725	11,428,674
Interest bearing:
Savings, NOW and money market	27,245,966	26,304,639
Time	12,270,067	12,342,544
Total deposits	51,175,758	50,075,857
Short-term borrowings	51,052	72,718
Long-term borrowings	2,905,898	3,174,155
Junior subordinated debentures issued to capital trusts	57,716	57,455
Lease liabilities	377,854	388,303
Accrued expenses and other liabilities	754,962	1,288,076
Total Liabilities	55,323,240	55,056,564
Shareholders’ Equity
Common stock (no par value, authorized 650,000,000 shares; issued 560,878,750 shares at September 30, 2025 and 558,786,093 shares at December 31, 2024)	196,731	195,998
Surplus	5,456,944	5,442,070
Retained earnings	1,787,141	1,598,048
Accumulated other comprehensive loss	(98,802)	(155,334)
Treasury stock, at cost (94,398 common shares at September 30, 2025)	(985)	0
Total Shareholders’ Equity	7,695,374	7,435,127
Total Liabilities and Shareholders’ Equity	63,018,614	62,491,691
Series A
Shareholders’ Equity
Preferred stock, no par value; 50,000,000 authorized shares:	111,590	111,590
Series B
Shareholders’ Equity
Preferred stock, no par value; 50,000,000 authorized shares:	98,101	98,101
Series C
Shareholders’ Equity
Preferred stock, no par value; 50,000,000 authorized shares:	$ 144,654	$ 144,654